SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Lupin informs about company updates

20 Dec 2019 Evaluate

Lupin has informed about the Press Note as regards Lupin facilitating a new initiative 'The Best of ACG ' in association with American College of Gastroenterology. This may be considered as a disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. 

The above information is a part of company’s filings submitted to BSE.

Lupin Share Price

2410.20 2.75 (0.11%)
30-Jun-2026 13:19 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1868.70
Dr. Reddys Labs. 1364.85
Cipla 1472.80
Zydus Lifesciences 1122.70
Lupin 2410.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: